Evidence map›Paper›PMID 32129528›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Azaruthena(II)-bicyclo[3.2.0]heptadiene: Key Intermediate for Ruthenaelectro(II/III/I)-catalyzed Alkyne Annulations.

Long Yang, Ralf Steinbock, Alexej Scheremetjew, Rositha Kuniyil, Lars H Finger, Antonis M Messinis, Lutz Ackermann

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Unlocking Catalysis Using Oxidatively Induced Reductive Elimination.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Electrooxidative Rhodium-Catalyzed [5+2] Annulations via C-H/O-H Activations.Angewandte Chemie (International ed. in English) · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Long YangInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Ralf SteinbockInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Alexej ScheremetjewInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Rositha KuniyilInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Lars H FingerInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Antonis M MessinisInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.
Lutz AckermannInstitut für Organische und Biomolekulare Chemie, and Wöhler Research Institute for Sustainable Chemistry, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077, Göttingen, Germany.ORCID http://orcid.org/0000-0001-7034-8772

Funding

China Scholarship CouncilDFG Gottfried-Wilhelm-Leibniz award
6 · The paper itself

Abstract

A ruthenium-catalyzed electrochemical dehydrogenative annulation reaction of imidazoles with alkynes has been established, enabling the preparation of various bridgehead N-fused [5,6]-bicyclic heteroarenes through regioselective electrochemical C-H/N-H annulation without chemical metal oxidants. Novel azaruthenabicyclo[3.2.0]heptadienes were fully characterized and identified as key intermediates. Mechanistic studies are suggestive of an oxidatively induced reductive elimination pathway within a ruthenium(II/III) regime.

Indexed as

C−H activationdehydrogenationelectrochemistrynitrogen heterocyclesruthenium

Identifiers

PMID32129528
PMCPMC7317209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.